The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,930
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,344
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationGeneral Conclusions: Teleonomic Mechanisms in Cellular Metabolism, Growth, and Differentiation
Monod, J., & Jacob, F. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.048 · Cited by 1,072
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationOperational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Self-citationAllosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Self-citationAllosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Self-citationKristiansen, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.002 · Cited by 609
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Costa, T., & Herz, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7321 · Cited by 536
Allosteric Modulation of the Cannabinoid CB1 Receptor
Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., McLean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 443
Self-citationAllosteric Receptors after 30 Years
Changeux, J.-P., & Edelstein, S. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80616-9 · Cited by 431
Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors
Hoare, S. R. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03370-2 · Cited by 379
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.004 · Cited by 363
Self-citationEhlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., Flor, P. J., Vranesic, I., Prézeau, L., Pin, J.-P., Thomsen, C., & Kuhn, R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12169-4 · Cited by 344
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Allostery: an illustrated definition for the ‘second secret of life’
Fenton, A. W. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.009 · Cited by 320
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Kinney, G. G., O’Brien, J. A., Lemaire, W., Burno, M., Bickel, D. J., Clements, M. K., Chen, T.-B., Wisnoski, D. D., Lindsley, C. W., Tiller, P. R., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079244 · Cited by 298
Sur, C., Mallorga, P. J., Wittmann, M., Jacobson, M. A., Pascarella, D., Williams, J. B., Brandish, P. E., Pettibone, D. J., Scolnick, E. M., & Conn, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835612100 · Cited by 294
Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
Pin, J.-P., Neubig, R., Bouvier, M., Devi, L., Filizola, M., Javitch, J. A., Lohse, M. J., Milligan, G., Palczewski, K., Parmentier, M., et al. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.5 · Cited by 277
THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS
CLARK, A. L., & MITCHELSON, F. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07708.x · Cited by 251
Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 247
Mitsukawa, K., Yamamoto, R., Ofner, S., Nozulak, J., Pescott, O., Lukic, S., Stoehr, N., Mombereau, C., Kuhn, R., McAllister, K. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508063102 · Cited by 239
Allosteric modulation of the muscarinic M 4 receptor as an approach to treating schizophrenia
Chan, W. Y., McKinzie, D. L., Bose, S., Mitchell, S. N., Witkin, J. M., Thompson, R. C., Christopoulos, A., Lazareno, S., Birdsall, N. J. M., Bymaster, F. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800567105 · Cited by 235
Self-citationCurrent Protocols in Pharmacology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471141755 · Cited by 225
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Kenakin, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.2 · Cited by 213
Kenakin, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.009 · Cited by 213
Discovery of an Ectopic Activation Site on the M1Muscarinic Receptor
Spalding, T. A., Trotter, C., Skjærbæk, N., Messier, T. L., Currier, E. A., Burstein, E. S., Li, D., Hacksell, U., & Brann, M. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12088-3 · Cited by 193
Baker, J. G., Hall, I. P., & Hill, S. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1357 · Cited by 189
Hall, D. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12715-0 · Cited by 187
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity
Antony, J., Kellershohn, K., Mohr‐Andrä, M., Kebig, A., Prilla, S., Muth, M., Heller, E., Disingrini, T., Dallanoce, C., Bertoni, S., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-114751 · Cited by 179
Self-citationAgonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
Valant, C., Gregory, K. J., Hall, N. E., Scammells, P. J., Lew, M. J., Sexton, P. M., & Christopoulos, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803801200 · Cited by 173
Self-citationEhlert, F. J. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14182-5 · Cited by 168
Analysis of Allosterism in Functional Assays
Ehlert, F. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090886 · Cited by 168
Allosteric functioning of dimeric class C G‐protein‐coupled receptors
Pin, J., Kniazeff, J., Liu, J., Binet, V., Goudet, C., Rondard, P., & Prézeau, L. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04728.x · Cited by 167
Leach, K., Loiacono, R. E., Felder, C. C., McKinzie, D. L., Mogg, A., Shaw, D. B., Sexton, P. M., & Christopoulos, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.194 · Cited by 167
Self-citationMarlo, J. E., Niswender, C. M., Days, E., Bridges, T. M., Xiang, Y., Rodriguez, A. L., Shirey-Rice, J. K., Brady, A. E., Nalywajko, T., Luo, Q., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052886 · Cited by 159
Aurelio, L., Valant, C., Flynn, B. L., Sexton, P. M., Christopoulos, A., & Scammells, P. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002582 · Cited by 144
Self-citationCharacterization of a CNS penetrant, selective M1muscarinic receptor agonist, 77‐LH‐28‐1
Langmead, C. J., Austin, N. E., Branch, C. L., Brown, J. T., Buchanan, K. A., Davies, C. H., Forbes, I. T., Fry, V. A. H., Hagan, J. J., Herdon, H. J., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.152 · Cited by 131
‘7TM Receptor Allostery: Putting Numbers to Shapeshifting Proteins
Kenakin, T. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.007 · Cited by 129
Allosterism at Muscarinic Receptors: Ligands and Mechanisms
Birdsall, N. J. M., & Lazareno, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054023251 · Cited by 126
Nawaratne, V., Leach, K., Suratman, N., Loiacono, R. E., Felder, C. C., Armbruster, B. N., Roth, B. L., Sexton, P. M., & Christopoulos, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049353 · Cited by 126
Self-citationGriffin, M. T., Figueroa, K. W., Liller, S., & Ehlert, F. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120857 · Cited by 123
Rational design of dualsteric GPCR ligands: quests and promise
Mohr, K., Tränkle, C., Kostenis, E., Barocelli, E., Amici, M. D., & Holzgrabe, U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00601.x · Cited by 117
Allosteric Modulation of Muscarinic Acetylcholine Receptors
Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2007) · Current Neuropharmacology · doi:10.2174/157015907781695946 · Cited by 115
Self-citationMathiesen, J. M., Ulven, T., Martini, L., Gerlach, L. O., Heinemann, Á., & Kostenis, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010520 · Cited by 100
Steinfeld, T., Mammen, M., Smith, J. A. M., Wilson, R. D., & Jasper, J. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033746 · Cited by 98
Hybrid Ortho/Allosteric Ligands for the Adenosine A1Receptor
Narlawar, R., Lane, J. R., Doddareddy, M. R., Lin, J., Brussee, J., & IJzerman, A. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901252a · Cited by 93
Orthosteric/Allosteric Bitopic Ligands: Going Hybrid at GPCRs
Valant, C., Sexton, P. M., & Christopoulos, A. (2009) · Molecular Interventions · doi:10.1124/mi.9.3.6 · Cited by 91
Self-citationPuia, G., Ducic, I., Vicini, S., & Costa, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3620 · Cited by 79
Disingrini, T., Muth, M., Dallanoce, C., Barocelli, E., Bertoni, S., Kellershohn, K., Mohr, K., Amici, M. D., & Holzgrabe, U. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050769s · Cited by 73
Nawaratne, V., Leach, K., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125096 · Cited by 70
Self-citationAvlani, V. A., Langmead, C. J., Guida, E., Wood, M. D., Tehan, B. G., Herdon, H. J., Watson, J. M., Sexton, P. M., & Christopoulos, A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064345 · Cited by 65
Self-citationWaelbroeck, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09800-1 · Cited by 60
Lebon, G., Langmead, C. J., Tehan, B. G., & Hulme, E. C. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050963 · Cited by 51
Receptor classification: post genome
Foord, S. M. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00214-x · Cited by 47
Leach, K., Sexton, P. M., & Christopoulos, A. (2011) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0122s52 · Cited by 39
Self-citationFunctional Selectivity in GPCR Modulator Screening
Kenakin, T. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708784534824 · Cited by 33
Stewart, G. D., Sexton, P. M., & Christopoulos, A. (2010) · ACS Chemical Biology · doi:10.1021/cb900276p · Cited by 30
Self-citationStewart, G. D., Sexton, P. M., & Christopoulos, A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064253 · Cited by 19
Self-citationPharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors
Christopoulos, A., & Mitchelson, F. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01379-4 · Cited by 18
Self-citation
Cited by
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
“Global curve fitting of allosterism data was carried out using the following operational model (Keov et al., 2011; Smith et al., 2011; Hudson et al., 2014):”
BackgroundMethodInfluentialActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Self-citationDiversity and modularity of G protein-coupled receptor structures
Katritch, V., Cherezov, V., & Stevens, R. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.003 · Cited by 456
Metadata
- Authors
- Keov, P., Sexton, P. M., & Christopoulos, A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 60
- Issue
- 1
- Pages
- 24-35
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2066514887
- Cited by
- 265
- References
- 75
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.